[1] CHAN HL, WONG VW, WONG GL, et al. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B[J]. Hepatology, 2010, 52 (4) :1232-1241.
|
[2] THOMPSON AJ, NGUYEN T, LSER D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers:Disease phase influences correlation with viral load and intra-hepatic hepatitis B virus markers[J]. Hepatology, 2010, 51 (6) :1933-1944.
|
[3] MONTAZERI G, RAHBAN M, MOHAMADNEJAD M, et al. Liver histology and HBV DN levels in chronically HBV infected patients with persistently normal alanine aminotransferase[J].Arch Iran Med, 2010, 13 (3) :193-202.
|
[4] MACMAHON BJ. The natural history of chronic hepatitis B virus infection[J]. Hepatology, 2009, 49:45.
|
[5] Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medcal Association. The guideline of prevention and treatment for chronic hepatitis B (2015 version) [J]. J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
[6] TSENG TC, LIU CJ, YANG HC, et al. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads[J]. Hepatology, 2013, 57 (2) :441-450.
|
[7] European Association for the Study of the Liver. EASL clinical practice guidelines:management of chronic hepatitis B virus infection[J]. Hepatel, 2012, 57 (1) :167-185.
|
[8] TRAN TT. Immune tolerant hepatitis B:A clinical dilemma[J].Gastroenterol Hepal, 2011, 7 (8) :511-516.
|
[9] QIU HF, LI JH, YANG WJ, et al. Analysis of related factors of ALT persistently normal patients with chronic HBV infection[J]. Chin J Nosocomiol, 2015, 25 (17) :3893-3895. (in Chinese) 邱惠芳, 李金花, 杨文君, 等.慢性乙型肝炎感染谷丙转氨酶持续正常患者肝脏病理相关因素分析[J].中华医院感染杂志, 2015, 25 (17) :3893-3895.
|
[10] LI W, XU KH, ZHAO SS. Association between liver pathology and clinical features in patients with chronic HBV infection and slightly elevated alanine aminotransferase[J]. J Clin Hepatol, 2017, 33 (11) :2123-2126. (in Chinese) 李伟, 徐葵花, 赵守松. ALT轻度升高的慢性HBV感染者临床特征与病理学的关系[J].临床肝胆病杂志, 2017, 33 (11) :2123-2126.
|
[11] DING HB, LI YX, LAI JQ, et al. Correlation between pathological changes of liver tissue and portal vein diameter in patients with chronic hepatitis B[J]. J Prac Hepatol, 2010, 13 (5) :369-370. (in Chinese) 丁红兵, 李奕鑫, 赖江琼, 等.慢性乙型肝炎患者肝组织病理学改变与门静脉内径的相关性分析[J].实用肝脏病杂志, 2010, 13 (5) :369-370.
|
[12] HUO XP, XIE QX, JIANG XP, et al. Pathological changes of liver tissues in 486 patients with chronic hepatitis B[J]. J Prac Hepatol, 2015, 18 (4) :360-363. (in Chinese) 霍雪平, 谢琴秀, 江晓平, 等. 486例慢性乙型肝炎患者肝组织病理学变化与肝功能指标的相关性研究[J].实用肝脏病杂志, 2015, 18 (4) :360-363.
|
[13] SUN HY, WANG M, LYU SJ, et al. Predictive factors of early diagnosis of liver cirrhosis in chronic HBV carriers[J/CD].Chin J Liver Dis:Electronic Edit, 2017, 9 (4) :82-85. (in Chinese) 孙海英, 王明, 吕胜军, 等.慢性HBV携带者早期肝硬化诊断的预测因素分析[J/CD].中国肝脏病杂志:电子版, 2017, 9 (4) :82-85.
|
[14] HUANG CM, YANG Z, NIE YQ, et al. Value of gamma-glutamyl transpeptidase-to-platelet ratioin predicting liver fibrosis stage in chronic hepatitis B patients in Guangdong, China[J]. J Clin Hepatol, 2018, 34 (6) :1204-1208. (in Chinese) 黄春明, 杨湛, 聂玉强, 等. GGT/PLT比值对广东地区慢性乙型肝炎患者肝纤维化分期的预测价值[J].临床肝胆病杂志, 2018, 34 (6) :1204-1208.
|
[15] LU HY, LIU LF, XU XY, et al. FibroScan in diagnosis of liver fibrosis in patients with different chronic liver diseases:A comparative analysis[J]. J Clin Hepatol, 2016, 32 (8) :1512-1517. (in Chinese) .陆海英, 刘玲峰, 徐小元, 等. FibroScan诊断不同类型慢性肝病肝纤维化的效果比较[J].临床肝胆病杂志, 2016, 32 (8) :1513-1517.
|
1. | 朱宏坤,戴芳芳,钱世宁. 血必净注射液对行连续性肾脏替代疗法的多器官功能障碍综合征患者凝血功能的影响. 哈尔滨医科大学学报. 2024(01): 75-79 . ![]() | |
2. | 肖晶晶. 局部枸橼酸抗凝联合CRRT治疗脓毒症合并急性肾衰竭的临床疗效及对患者凝血功能的影响. 延边大学医学学报. 2024(05): 534-537 . ![]() | |
3. | 王娟,张丽萍,丁童,卫淑润,翁志华. 局部枸橼酸抗凝血液净化技术在ICU造血干细胞移植后弥漫性肺泡出血患者治疗中应用价值. 临床军医杂志. 2023(05): 522-524 . ![]() | |
4. | 孙卫和,许伟伟,冒秀宏,汪涛. 局部枸橼酸抗凝在重症急性肾损伤患者连续性肾脏替代治疗中的应用. 中外医疗. 2023(18): 129-132 . ![]() | |
5. | 赵志强,孟鹏飞,石正松,陈亚君,肖宏涛. 枸橼酸抗凝在脓毒症伴高危出血行连续性肾脏替代治疗患者中的应用效果. 医药论坛杂志. 2023(19): 14-18 . ![]() | |
6. | 李一青,白银果,沙莎. 连续性静脉-静脉血液滤过透析和局部枸橼酸抗凝在重症患者乳酸升高时应用的有效性和安全性研究. 贵州医药. 2023(11): 1704-1705 . ![]() | |
7. | 张妍,荣阳,张芳. CRRT治疗肾衰竭合并顽固性心力衰竭的临床效果. 中西医结合心脑血管病杂志. 2022(02): 285-288 . ![]() | |
8. | 张竞葳,田敏,余建斌. 局部枸橼酸抗凝应用于维持性血液透析合并消化道出血患者的疗效观察. 现代医学与健康研究电子杂志. 2022(13): 130-134 . ![]() | |
9. | 陈伟玲,邓虹,黄颖妍,李乐,张洪举. 局部枸橼酸抗凝在连续性肾替代疗法治疗中的效果及安全性指标的变化. 北方药学. 2022(05): 116-119 . ![]() | |
10. | 吴允东,江海娇,张伟,曹迎亚,杨尚志,周伟. 不同抗凝方案用于心脏术后患者连续性肾脏替代治疗中的效果. 皖南医学院学报. 2022(05): 436-439+443 . ![]() | |
11. | 严海燕,黄雪敏,李大亮,岑树坤,蒋林青. 局部枸橼酸抗凝在重症急性肾损伤患者连续性肾脏替代治疗中的应用分析. 实用中西医结合临床. 2022(17): 31-33+37 . ![]() | |
12. | 金源源,诸炳骅,费雪洁,王倩. 局部枸橼酸抗凝在肝衰竭患者连续性肾脏替代治疗中的应用. 临床肝胆病杂志. 2021(01): 200-203 . ![]() | |
13. | 胡新,毛智,周飞虎. 枸橼酸抗凝在重症患者连续血液净化中的应用进展. 武警医学. 2021(01): 78-81 . ![]() | |
14. | 杨向莎,杨福燕,张瑞霞,张军. 改良式枸橼酸钠与低分子量肝素在急性肾损伤CRRT中的抗凝效果比较. 临床医学研究与实践. 2021(20): 46-49 . ![]() | |
15. | 冉梦晓,陈辉,郑浩天. 枸橼酸局部抗凝技术在血液透析中的应用进展. 中国医药. 2021(07): 1113-1116 . ![]() | |
16. | 杨妮娜,李之诉,杨禄,陈王峰. RCA-CRRT治疗中滤器后离子钙与体内离子钙的相关性. 现代实用医学. 2021(08): 993-995 . ![]() | |
17. | 焦清海,郑丽环,张雪梅,王征,杜菲,陈亮. 局部枸橼酸抗凝在危重症患者持续肾脏替代疗法中的临床应用. 河北医科大学学报. 2021(10): 1144-1148 . ![]() | |
18. | 王敬文. 枸橼酸与肝素抗凝对重症血液净化患者临床指标和安全性的影响比较. 中外医学研究. 2021(32): 40-43 . ![]() | |
19. | 冯菁,李和文,张兴凯,王建华,张作鹏,郭燕蓉,任航奇. 肝衰竭患者行局部枸橼酸抗凝连续性肾脏替代治疗时发生枸橼酸蓄积的影响因素分析. 临床和实验医学杂志. 2021(22): 2402-2406 . ![]() | |
20. | 李杨,由丽丽. 连续性肾脏替代治疗脑出血合并急性肾损伤患者中应用局部枸橼酸抗凝治疗的有效性及安全性. 中国医药指南. 2020(36): 89-90 . ![]() |